Several new drugs have been approved to treat rare genetic disorders: setmelanotide for certain conditions causing obesity; lumasiran for primary hyperoxaluria type 1, a kidney disorder; and lonafarnib for two diseases that cause premature aging.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/01.NAJ.0000734120.60377.79 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!